Arcturus Therapeutics: Q1 Earnings Insights

Arcturus Therapeutics ARCT reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.

Arcturus Therapeutics beat estimated earnings by 3016.67%, reporting an EPS of $1.87 versus an estimate of $0.06.

Revenue was up $75.04 million from the same period last year.

Last quarter the company beat on EPS by $3.35 which was followed by a 30.13% increase in the share price the next day.

Here's a look at Arcturus Therapeutics's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	0.98	-1.81	-1.90	-1.44
EPS Actual	4.33	-1.33	-0.82	-1.94
Revenue Estimate	72.68M	3.42M	2.09M	6.30M
Revenue Actual	160.29M	13.37M	27.09M	5.24M

To track all earnings releases for Arcturus Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar